MedPage Today1d
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
Marketing Dive1d
Bayer Achieves 32% Increase in Media Efficiency With Incremental and Skai
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
Campaign US1d
Exclusive: How Bayer cracked the retail media code
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
FiercePharma2d
JPM25: Bayer gears up for 'must-win battles' as Xarelto's decline is in full swing, pharma chief says
These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
Hosted on MSN3d
Daily Low Dose Of Aspirin Is Not As Good As You Think
People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...
Bayer Says It Was Told by Jury to Pay $100 Million Over Toxic Chemicals
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the ...
Bayer Hit With $100 Million Verdict Over School’s Toxic PCBs (2)
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain ...
Bayer sees new drugs boosting return to growth in 2027, WSJ reports
Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...